{{Drugbox
| verifiedrevid = 444190640
| IUPAC_name = 2-(1-aminopropyl)indan-2-ol
| image = Indanorex.png

<!--Clinical data-->
| tradename =  
| pregnancy_category =  
| legal_status =  
| routes_of_administration =

<!--Pharmacokinetic data-->
| bioavailability =  
| metabolism =  
| elimination_half-life =  
| excretion =

<!--Identifiers-->
| CAS_number = 16112-96-2
| ATC_prefix = none
| ATC_suffix =  
| PubChem = 65623
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 59064
| ChEMBL = 2105009
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 982LOO7DEE

<!--Chemical data-->
| C=12 | H=17 | N=1 | O=1 
| molecular_weight = 191.269 g/mol
| smiles = OC2(Cc1ccccc1C2)C(N)CC
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C12H17NO/c1-2-11(13)12(14)7-9-5-3-4-6-10(9)8-12/h3-6,11,14H,2,7-8,13H2,1H3
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = QTZFSVVIXMRRLW-UHFFFAOYSA-N
}}

'''Indanorex''' ('''Dietor''') is a [[stimulant]] drug which was developed in the 1970s. It has [[appetite suppressant]] effects [http://www.psychotropics.dk/usr_view_molecule.asp?ID=2154&backurl=Codeindex%2Fview_Codes.asp%3FStartchar%3DJ&backurlname=Code+numbers&Catalogtype=A&historyline=] and also has anti[[hypoglycemia]] effects.<ref>Giugliano D, Luyckx A, Binder D, Lefebvre P. Comparative effects of metformin and indanorex in the treatment of reactive hypoglycemia. ''International Journal of Clinical Pharmacology and Biopharmacy''. 1979 Feb;17(2):76-81.</ref>

== See also ==
* [[Aminoindane]]

== References ==
{{Reflist}}

{{Stimulants}}
{{Anorectics}}
{{Monoamine releasing agents}}

[[Category:Alcohols]]
[[Category:Anorectics]]
[[Category:Indanes]]
[[Category:Stimulants]]
[[Category:Norepinephrine-dopamine releasing agents]]


{{gastrointestinal-drug-stub}}